Annual EBIT:
-$26.62M+$10.28M(+27.85%)Summary
- As of today, XERS annual earnings before interest & taxes is -$26.62 million, with the most recent change of +$10.28 million (+27.85%) on December 31, 2024.
- During the last 3 years, XERS annual EBIT has risen by +$88.93 million (+76.96%).
- XERS annual EBIT is now -101.55% below its all-time high of -$13.21 million, reached on December 31, 2016.
Performance
XERS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$6.73M+$2.25M(+50.18%)Summary
- As of today, XERS quarterly earnings before interest & taxes is $6.73 million, with the most recent change of +$2.25 million (+50.18%) on September 30, 2025.
- Over the past year, XERS quarterly EBIT has increased by +$19.62 million (+152.21%).
- XERS quarterly EBIT is now at all-time high.
Performance
XERS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$9.80M+$19.62M(+199.80%)Summary
- As of today, XERS TTM earnings before interest & taxes is $9.80 million, with the most recent change of +$19.62 million (+199.80%) on September 30, 2025.
- Over the past year, XERS TTM EBIT has increased by +$54.97 million (+121.70%).
- XERS TTM EBIT is now at all-time high.
Performance
XERS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
XERS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +27.9% | +152.2% | +121.7% |
| 3Y3 Years | +77.0% | +136.0% | +109.4% |
| 5Y5 Years | +77.6% | +152.0% | +110.2% |
XERS EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +77.0% | at high | +136.0% | at high | +109.4% |
| 5Y | 5-Year | at high | +77.6% | at high | +117.3% | at high | +108.4% |
| All-Time | All-Time | -101.5% | +77.6% | at high | +117.3% | at high | +107.8% |
XERS EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $6.73M(+50.2%) | $9.80M(+199.8%) |
| Jun 2025 | - | $4.48M(+245.0%) | -$9.82M(+56.3%) |
| Mar 2025 | - | -$3.09M(-284.0%) | -$22.49M(+33.2%) |
| Dec 2024 | -$26.62M(+27.9%) | $1.68M(+113.0%) | -$33.65M(+25.5%) |
| Sep 2024 | - | -$12.89M(-57.5%) | -$45.17M(-21.5%) |
| Jun 2024 | - | -$8.19M(+42.5%) | -$37.19M(+17.3%) |
| Mar 2024 | - | -$14.24M(-44.8%) | -$44.98M(-2.2%) |
| Dec 2023 | -$36.90M(+55.0%) | -$9.84M(-100.3%) | -$44.01M(+10.8%) |
| Sep 2023 | - | -$4.91M(+69.3%) | -$49.34M(+21.8%) |
| Jun 2023 | - | -$15.98M(-20.4%) | -$63.13M(+4.4%) |
| Mar 2023 | - | -$13.28M(+12.5%) | -$66.07M(+17.9%) |
| Dec 2022 | -$81.98M(+29.0%) | -$15.17M(+18.9%) | -$80.45M(+22.8%) |
| Sep 2022 | - | -$18.70M(+1.1%) | -$104.15M(+5.1%) |
| Jun 2022 | - | -$18.92M(+31.6%) | -$109.81M(+5.7%) |
| Mar 2022 | - | -$27.66M(+28.8%) | -$116.48M(-10.7%) |
| Dec 2021 | -$115.55M | -$38.87M(-59.6%) | -$105.26M(-24.1%) |
| Sep 2021 | - | -$24.36M(+4.8%) | -$84.83M(-15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$25.59M(-55.6%) | -$73.41M(-4.8%) |
| Mar 2021 | - | -$16.44M(+10.9%) | -$70.03M(+14.4%) |
| Dec 2020 | -$80.59M(+32.2%) | -$18.44M(-42.5%) | -$81.85M(+14.9%) |
| Sep 2020 | - | -$12.94M(+41.7%) | -$96.20M(+15.1%) |
| Jun 2020 | - | -$22.20M(+21.4%) | -$113.34M(+9.5%) |
| Mar 2020 | - | -$28.25M(+13.9%) | -$125.20M(-2.3%) |
| Dec 2019 | -$118.88M(-106.6%) | -$32.80M(-9.0%) | -$122.38M(-11.4%) |
| Sep 2019 | - | -$30.08M(+11.7%) | -$109.89M(-16.0%) |
| Jun 2019 | - | -$34.06M(-33.9%) | -$94.75M(-29.7%) |
| Mar 2019 | - | -$25.44M(-25.2%) | -$73.05M(-23.1%) |
| Dec 2018 | -$57.53M(-116.7%) | -$20.31M(-35.9%) | -$59.34M(-52.0%) |
| Sep 2018 | - | -$14.94M(-20.9%) | -$39.03M(-23.3%) |
| Jun 2018 | - | -$12.36M(-5.3%) | -$31.66M(-64.0%) |
| Mar 2018 | - | -$11.73M(-54.9%) | -$19.30M(-57.9%) |
| Dec 2017 | -$26.55M(-101.0%) | - | - |
| Sep 2017 | - | -$7.57M(-62.9%) | -$12.22M(-162.9%) |
| Mar 2017 | - | -$4.65M | -$4.65M |
| Dec 2016 | -$13.21M | - | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual EBIT year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly EBIT year-on-year change?
- What is Xeris Biopharma Holdings, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. TTM EBIT year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual earnings before interest & taxes?
The current annual EBIT of XERS is -$26.62M
What is the all-time high annual EBIT for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual earnings before interest & taxes is -$13.21M
What is Xeris Biopharma Holdings, Inc. annual EBIT year-on-year change?
Over the past year, XERS annual earnings before interest & taxes has changed by +$10.28M (+27.85%)
What is Xeris Biopharma Holdings, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of XERS is $6.73M
What is the all-time high quarterly EBIT for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly earnings before interest & taxes is $6.73M
What is Xeris Biopharma Holdings, Inc. quarterly EBIT year-on-year change?
Over the past year, XERS quarterly earnings before interest & taxes has changed by +$19.62M (+152.21%)
What is Xeris Biopharma Holdings, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of XERS is $9.80M
What is the all-time high TTM EBIT for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high TTM earnings before interest & taxes is $9.80M
What is Xeris Biopharma Holdings, Inc. TTM EBIT year-on-year change?
Over the past year, XERS TTM earnings before interest & taxes has changed by +$54.97M (+121.70%)